2011 – 2012

  • Acosta DM, Soprano LL, Ferrero M, Landoni M, Esteva MI, Couto AS, Duschak VG. A striking common O-linked N-acetylglucosaminyl moiety between cruzipain and myosin. Parasite Immunol. 2011 Jul; 33(7): 363-70.
  • Cutrullis RA, Moscatelli GF, Moroni S, Volta BJ, Cardoni RL, Altcheh JM, Corral RS, Freilij HL, Petray PB. Benznidazole therapy modulates interferon-? and M2 muscarinic receptor autoantibody responses in Trypanosoma cruzi-infected children. PLoS One. 2011;6 (10):e27133..
  • Cutrullis RA, Poklépovich TJ, Postan M, Freilij HL, Petray PB. Immunomodulatory and anti-fibrotic effects of ganglioside therapy on the cardiac chronic form of experimental Trypanosoma cruzi infection. Int Immunopharmacol.2011. 11(8):1024-31
  • Duschak Vilma G. A decade of targets and patented drugs for chemotherapy of Chagas Disease. Recent Patents in Anti-infective drug discovery, 2011; 6(3):216-59.
  • Pérez de Rosas AR, Segura EL, García BA. Molecular phylogeography of the Chagas’ disease vector Triatoma infestans in Argentina Heredity (Edinb). 2011. 107(1):71-9.
  • Viotti R, Vigliano C, Alvarez MG, Lococo B, Petti M, Bertocchi G, Armenti A, De Rissio AM, Cooley G, Tarleton R, Laucella S. Impact of aetiological treatment on conventional and multiplex serology in chronic Chagas disease. PLoS Negl Trop Dis. 2011. 5(9):e1314.
  • Schijman AG, Bisio M, Orellana L, Sued M, Duffy T, Mejia Jaramillo AM, Cura C, Auter F, Veron V, Qvarnstrom Y, Deborggraeve S,Hijar G, Zulantay I, Lucero RH, Velazquez E, Tellez T, Sanchez Leon Z, Galvão L, Nolder D, Monje Rumi M, Levi JE, Ramirez JD,Zorrilla P, Flores M, Jercic MI, Crisante G, Añez N, De Castro AM, Gonzalez CI, Acosta Viana K, Yachelini P, Torrico F, Robello C,Diosque P, Triana Chavez O, Aznar C, Russomando G, Büscher P, Assal A, Guhl F, Sosa Estani S, DaSilva A, Britto C, Luquetti A,Ladzins J. International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients. PLoS Negl Trop Dis. 2011. 5(1):e931.
  • Avila ML, Tekiel V, Moretti G, Nicosia S, Búa J, Lammel EM, Stroppa MM, Gerez de Burgos NM, Sánchez DO. Gene discovery in Triatoma infestans. Parasit Vectors. 2011. 4:39.
  • Schijman AG, Bisio M, Orellana L, Sued M, Duffy T. International Study to Evaluate PCR Methods for Detection of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients., et al. (2011) PLoS Negl Trop Dis 5(1): e931.
  • Caiaffa WT, Zocratto KF, Osimani ML, Martínez PL, Radulich G, Latorre L, Muzzio E, Segura M, Chiparelli H, Russi J, Rey J, Vazquez E, Cuchi P, Sosa-Estani S, Rossi D, Weissenbacher M. Hepatitis C virus among non-injecting cocaine users (NICUs) in South America: can injectors be a bridge. Addiction. 2011 Jan;106(1):143-51.
  • Gamboa-León R, Gonzalez-Ramirez C, Padilla-Raygoza N, Sosa-Estani S, Caamal-Kantun A, Buekens P, Dumonteil E. Do Commercial Serologic Tests for Trypanosoma cruzi Infection Detect Mexican Strains in Women and Newborns?. J Parasitol. 2011 Apr;97(2):338-43.
  • Carlier Y, Torrico F, Sosa-Estani S, Russomando G, Luquetti A, Freilij H, Albajar-Viñas P. Congenital transmission of Trypanosoma cruzi infection (congenital Chagas disease). Recommendations for diagnosis, treatment and control of newborns, siblings and pregnant women. Plos Neglected Tropical Diseases. Accepted. June 2011.
  • Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in non endemic areas. María-Jesús Pinazo, Blanca Miranda, Camino Rodríguez-Villar, Javier Altclas, Mercè Brunet Serra, Elías Cañas García-Otero, Eros Antonio de Almeida, Manuel de la Mata García, Joaquim Gascon, Magdalena García Rodríguez, Nicolás Manito, Asunción Moreno Camacho, Federico Oppenheimerl, Sabino Puente Puente, Adelina Riarte, Joaquín Salas Coronas, Miguel Salavert Lletí, Guillermo F. Sanz, Faustino Torrico, Diego Torrús Tendero, Piedad Ussetti, Maria Aparecida Shikanai-Yasuda. Transplantation Review. 2011. doi:10.1016/j.trre.2010.12.002
  • Acosta DM, Soprano LL, Ferrero MR, Esteva MI, Riarte A, Couto AS, Duschak VG. Structural and immunological characterization of sulphatides: relevance of sulphate moieties in Trypanosoma cruzi glycoconjugates.Parasite Immunol. 2012 Nov; 34(11):499-510.
  • Argüello RJ, Albareda MC, Alvarez MG, Bertocchi G, Armenti AH, Vigliano C, Meckert PC, Tarleton RL, Laucella SA. Inhibitory receptors are expressed by Trypanosoma cruzi-specific effector T cells and in hearts of subjects with chronic Chagas disease. PLoS One. 2012;7(5):e35966. doi: 10.1371/journal.pone.0035966. Epub 2012 May 4.
  • Bua J, Volta BJ, Velazquez EB, Ruiz AM, Rissio AM, Cardoni RL. Vertical transmission of Trypanosoma cruzi infection: quantification of parasite burden in mothers and their children by parasite DNA amplification. Trans R Soc Trop Med Hyg. 2012 Oct;106(10):623-8. doi: 10.1016/j.trstmh.2012.03.015. Epub 2012 Jul 24.
  • Couto AS, Soprano LL, Landoni M, Pourcelot M, Acosta DM, Bultel L, Parente J, Ferrero MR, Barbier M, Dussouy C, Esteva MI, Kovensky J, Duschak VG. An anionic synthetic sugar containing 6-SO3 -NAcGlc mimics the sulfated cruzipain epitope that plays a central role in immune recognition. FEBS J. 2012 Oct;279(19):3665-79. doi: 10.1111/j.1742-4658.2012.08728.x. Epub 2012 Sep 4.
  • Cura CI, Lucero RH, Bisio M, Oshiro E, Formichelli LB, Burgos JM, Lejona S, Brusés BL, Hernández DO, Severini GV, Velazquez E, Duffy T, Anchart E, Lattes R, Altcheh J, Freilij H, Diez M, Nagel C, Vigliano C, Favaloro L, Favaloro RR, Merino DE, Sosa-Estani S, Schijman AG. Trypanosoma cruzi discrete typing units in Chagas disease patients from endemic and non-endemic regions of Argentina. Parasitology. 2012 Apr;139(4):516-21.
  • Gulin JE, Eagleson MA, Postan M, Cutrullis RA, Freilij H, Bournissen FG, Petray PB, Altcheh J. Efficacy of voriconazole in a murine model of acute Trypanosoma cruzi infection. J Antimicrob Chemother. 2012 Dec 4. [Epub ahead of print]
  • Lai DH, Bontempi EJ, Lukeš Trypanosoma brucei solanesyl-diphosphate synthase localizes to the mitochondrion. J. Mol Biochem Parasitol. 2012 Jun;183(2):189-92.
  • Pérez-Mazliah D, Albareda MC, Alvarez MG, Lococo B, Bertocchi GL, Petti M, Viotti RJ, Laucella SA. Allopurinol reduces antigen-specific and polyclonal activation of human T cells.Front Immunol. 2012;3:295. doi: 10.3389/fimmu.2012.00295. Epub 2012 Sep 21.
  • Sosa-Estani S, Colantonio L, Segura EL. Therapy of Chagas disease: implications for levels of prevention. J Trop Med. 2012;2012:292138.
  • Perez-Mazliah DE, Alvarez MG, Cooley G, Lococo BE, Bertocchi G, Petti M, Albareda MC, Armenti AH, Tarleton RL, Laucella SA, Viotti R. Sequential combined treatment with allopurinol and benznidazole in the chronic phase of Trypanosoma cruzi infection: a pilot study. J Antimicrob Chemother. 2012 Nov 1. [Epub ahead of print]